Official websites use .gov
A
.gov website belongs to an official government
organization in the United States.
Secure .gov websites use HTTPS
A
lock (
) or https:// means you’ve safely connected to
the .gov website. Share sensitive information only on official,
secure websites.
COSSUP
16.838
Goal: The Comprehensive Opioid, Stimulant, and other Substances Use Program (COSSUP), formerly COSSAP, was developed as part of the Comprehensive Addiction and Recovery Act (CARA) legislation. COSSUP’s goal is to provide financial and technical assistance to states, units of local government, and Indian tribal governments to develop, implement, or expand comprehensive efforts to identify, respond to, treat, and support those impacted by illicit opioids, stimulants, and other drugs of use. Objective: To address this goal, the COSSUP program, administered by BJA, provides funding through a competitive grant program to encourage and support comprehensive cross-system planning and collaboration among officials who work in law enforcement, pretrial services, the courts, probation and parole, child welfare, reentry, emergency medical services and healthcare providers, public health partners, and agencies who provide substance misuse treatment and recovery support services. Performance Measure 1: Percentage of COSSUP grantees who are using grant funds to operate diversion programs; Performance Measure 2: Number of individuals who have received naloxone training; Performance Measure 3: Number of individuals referred to substance use or co-occurring treatment; Performance Measure 4: Number of individuals referred recovery support services; and Performance Measure 5: Percentage of grantees using COSSSUP funds for medication-assisted treatment.
This chart shows obligations for the program by fiscal year. All data for this chart was provided by the
administering agency and sourced from SAM.gov, USASpending.gov, and Treasury.gov.
For more information on each of these data sources, please see the
About the data page.
Not Applicable.
BJA received 142 applications and funded 27 grants to support state, local and tribal initiatives.
12 awards were made to assist law enforcement and other first responders in obtaining naloxone, connecting survivors of non-fatal overdoses to services post-naloxone deployment, and establishing law enforcement diversion programs. Two awards were made to assist rural states in connecting individuals in the criminal justice system to treatment and recovery services via technology. Eight awards were made to expand diversion programs for low-level non-violent offenders and 5 awards were made to support planning efforts.
BJA received 112 applications and anticipates funding approximately 108 awards.
It is anticipated that 180 applications will be received.
• BJA is currently supporting an extensive portfolio of law enforcement and public health/behavioral health diversion projects (49 project from FY 2017 and 2018). • 48 grant awards established or expanded court-based or prosecutor-based programs for low-level, non-violent offenders. • 29 grant awards implemented or expanded evidence-based treatment in jails and prisons and support services upon reentry. • 48 grant awards implemented public education/awareness campaigns. • 12 grant awards strengthened PDMPs by integrating PDMPs with EHRs/HIEs. • 7 grant awards improved the quality and timeliness of data submitted to the PDMP from pharmacies.
BJA awarded more than $137 million under its Comprehensive Opioid, Stimulant and Substance Abuse Site-Based Program, which is helping communities address the prevention, diversion, treatment and recovery needs of those affected by substance use disorders. Another $9.7 million is funding related training and technical assistance.
BJA and various partners launched demonstration projects that strategically blend funding from multiple Federal agencies and promote public-philanthropic partnerships. These demonstration projects will strengthen our understanding of effective community responses to illicit substance use and misuse, expand adoption of effective practices and support innovation, and build capacity in those communities most impacted by substance use disorder. • National Initiative to Expand Opioid Use Disorder Treatment in Jails: Building Bridges Between Jails and Community-Based Treatment • Overdose Detection and Mapping Application Program (ODMAP) Statewide Expansion and Response • Partnerships to Support Data-driven Responses to Emerging Drug Threats • Rural Responses to the Opioid Epidemic.
To view demonstration projects visit: https://www.cossapresources.org/Program/DemoProjects
Please visit https://bja.ojp.gov/program/cossup/about
Since 2017, through COSSUP, BJA has supported innovative work—from coast to coast, in large cities and rural America, in tribal lands and United States territories—by over 590 site-based projects and demonstration sites. These projects have included grants related to the distribution of opioid antagonists like naloxone, establishment of overdose fatality review programs to identify system gaps and overdose death prevention strategies, and that focus on treatment and education for health care providers, criminal justice system professionals, and SUD treatment personnel. COSSUP funding highlights, data, and an assessment of activities of COSSUP grantees the years 2021 and 2022 can be found at: https://bja.ojp.gov/library/publications/comprehensive-opioid-stimulant-and-substance-use-program-key-performance.
Single Audit Applies (2 CFR Part 200 Subpart F):
For additional information on single audit requirements for this program, review the current Compliance Supplement.
OMB is working with the U.S. Government Accountability Office (GAO) and agency offices of inspectors general to include links to relevant oversight reports. This section will be updated once this information is made available.
